Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China. It has raised $120M in total funding. Latest round: Series A.
Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China. Innoforce Pharmaceuticals has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for Innoforce Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include South China Venture Capital, Yanchuang Capital, Quan Capital Management, Advantech Capital, CICC Capital Management. 5 distinct backers are named across the disclosed rounds.
Innoforce Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hangzhou below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026